JAK inhibitor SAR-20347, Purity ≥98%

Cat. No.: X23-10-ZQ416

JAK inhibitor SAR-20347, Purity ≥98%

Synonym: SAR-20347; 1450881-55-6; 2-(2-Chloro-6-fluorophenyl)-5-((4-(morpholine-4-carbonyl)phenyl)amino)oxazole-4-carboxamide; SAR20347; 2-(2-Chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-4-oxazolecarboxamide; 2-(2-Chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-4-oxazolecarboxamide; JAK inhibitor

  • CAS Number: 1450881-55-6
  • Compound CID: 71727668
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SAR-20347, soluble in DMSO and insoluble in ethanol and water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, and Tyk2.
Molecular Weight
444.84
Molecular Formula
C21H18ClFN4O4
Targets
JAK1: 23 nM; JAK2: 46 nM; JAK3: 41 nM; Tyk2: 0.6 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 77 mg/mL (173.09 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
SAR-20347 can be researched for its dual inhibition of JAK1 and Tyk2, with application in autoimmune disease models.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.